News & Updates

A prospective cohort study has linked prenatal use of aspirin to better neurocognitive development in offspring.

In healthy individuals with functional constipation, probiotics supplementation does not appear to increase bowel movement frequency as compared with placebo, according to a study.

Deucravacitinib, an oral selective inhibitor of tyrosine kinase 2 (TYK2), shows promise in the treatment of lichen planopilaris (LPP), with substantial reductions in disease activity, according to the interim analysis of an open-label, single-arm trial.

Treatment with lithium aspartate yields no significant effect on long COVID symptoms of fatigue and cognitive dysfunction, as shown in a study.

Treatment with upadacitinib demonstrated superior efficacy in achieving near-complete skin clearance and little to no itch at 16 weeks compared with dupilumab among adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to the LEVEL UP study presented at EADV 2024.

The interleukin-17 blocker bimekizumab delivers sustained clinical benefits lasting up to 2 years for patients with moderate-to-severe hidradenitis suppurativa, as reported in a late-breaking presentation at EADV 2024.

Treatment with tranexamic acid does not appear to reduce blood transfusion in patients during open radical cystectomy for bladder cancer, as shown in the results of the Tranexamic Acid During Cystectomy Trial (TACT).